Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Joe Wolk
Pharma
J&J's Kenvue spinoff provides $13.2B in potential M&A firepower
Johnson & Johnson said that its spinoff of consumer health unit Kenvue has generated $13.2 billion, providing the company lots of M&A firepower.
Kevin Dunleavy
Aug 30, 2023 10:45am
J&J takes major hit from litigation cost in 2023's first quarter
Apr 18, 2023 11:15am
J&J is letting go of 64 staffers in Manhattan
Oct 20, 2022 10:59am
J&J reduces revenue forecast for 2022, dropping vaccine sales
Apr 19, 2022 11:08am
The 'new J&J' will be more aggressive about deals, CEO says
Jan 25, 2022 11:56am
Stelara, Tremfya, Darzalex fuel strong 3rd quarter for J&J
Oct 19, 2021 11:25am
